Neurogait

Using AI to screen Curable Dementia and other Neurological disease

Health Tech & Life Sciences
Active
Seed Ra'anana Founded 2019
Total raised
Last: Seed 2019-07
Stage
Seed
Founded
2019
Headcount
3
HQ
Ra'anana
Sector
Health Tech & Life Sciences

About

Neurogait is developing AI based clinical screenings for neurodegenerative Disease including curable dementia, Parkinson's

It is currently conducting clinical pilots in Germany and is integrating its solution under a commercial agreement with a large on-line European patient platform. It is also working on its regulatory approvals.

Funding history · 1 round · — total

2019-07
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Technologies
SensingArtificial IntelligenceDeep LearningComputer VisionMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsMedical Devices Industry
Business model
B2B2CB2B

Highlights

Verified

Tags

deep-learningneurosciencedigital-healthcaremachine-learningneurologyartificial-intelligencealzheimers-diseasecomputer-visionparkinsonhome-caremedical-technologiesmachine-visiondiagnosticssensorsearly-detectionmedical-devices